{"symbol":"PFE","fiscalQuarter":"Q3-2018","reportDate":"2018-10-30","reportTime":"BMO","status":"reported","company":{"name":"Pfizer Inc.","sector":"Health Care","industry":"Pharmaceuticals"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/PFE/earnings/Q3-2018","postBrief":{"headline":"Pfizer Misses on EPS, Stock Down 0.79%","keyNumbers":[{"metric":"EPS","actual":"$0.78","expected":"N/A","surprise":"-0.21%"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["Management highlighted ongoing challenges in the market.","They emphasized a focus on innovation and pipeline development."],"summary":"Overall, management acknowledged the competitive landscape while expressing confidence in their future product pipeline. They did not provide specific guidance for the upcoming quarters."},"guidanceChanges":{"summary":"No guidance data was provided in this earnings report.","changes":[]},"whatItMeans":"Pfizer's earnings report showed a slight miss on EPS, which contributed to a 0.79% decline in stock price. The lack of revenue data and guidance may have raised concerns among investors about the company's future performance. Management's cautious tone suggests they are aware of market challenges but remain focused on their product development efforts.","metaDescription":"Pfizer Inc (PFE) Q3 2018 earnings: EPS missed. Stock down 0.79%. Full breakdown."}}